Table 1.
Patient characteristics
| Transjugular approach ( n =10) | Transfemoral approach ( n =13) | p -value | |
|---|---|---|---|
| Age (y) | 63.1 ± 14.2 | 59.6 ± 9.3 | 0.3 |
| Male gender (n) | 7 (70%) | 9 (69%) | 1 |
| Tumor type (n) | 0.65 | ||
| Metastases | 7 (70%) | 9 (69%) | |
| Cholangiocarcinoma | 3 (30%) | 3 (23%) | |
| Hepatocellular carcinoma | 0 (0%) | 1 (8%) | |
| Cirrhosis (n) | 0 (0%) | 1 (8%) | 1 |
| Neoadjuvant chemotherapy (n) | 6 (60%) | 10 (77%) | 0.65 |
| Proposed type of surgery (n) | 0.17 | ||
| Hemihepatectomy | 3 (30%) | 5 (38%) | |
| Hemihepatectomy + wedge resection | 1 (10%) | 5 (38%) | |
| Extended hemihepatectomy | 4 (40%) | 3 (23%) | |
| Extended hemihepatectomy + wedge resection | 2 (20%) | 0 (0%) | |